Menu
Το καλάθι σας

The Science of the Brain Function, Dysfunction and Disease

The Science of the Brain Function, Dysfunction and Disease
ΝΕΟ
The Science of the Brain Function, Dysfunction and Disease
  • Συγγραφείς: Ari Rappoport
  • ISBN: 9780443450082
  • Εκδότης: Academic Press
  • Σελίδες: 358
  • Διαστάσεις: 15 x 22 cm
  • Έτος Έκδοσης: 2025
157,00€
174,00€
Χωρίς ΦΠΑ: 148,11€

The Science of the Brain: Function, Dysfunction and Disease is an innovative exploration into the complex interplay between brain functionality and various neurological disorders, meticulously compiled by a world-renowned researcher. This groundbreaking book presents a comprehensive analysis, offering the first complete theories for eleven major brain disorders, including Alzheimer’s, schizophrenia, and autism spectrum disorder, among others. Each chapter delves into a unique theoretical framework, from lipid raft theories to sympathetic nervous system impacts, all while proposing potential treatment targets grounded in established scientific data. In addition to two chapters that lay the groundwork for understanding brain adaptability and anatomy, other chapters independently dissect each disorder, revealing fresh insights that promise to invigorate research and clinical application. This essential resource not only serves neuroscientists and clinicians seeking a deeper understanding of brain disorders but also invites entrepreneurs interested in novel therapeutic avenues. With its rich references and pioneering theories, this book is poised to become indispensable to students, researchers and clinicians, paving the way for future discoveries in brain health and disease management.

  • Identifies connections between brain functionality and specific disorders, revealing previously unexplored therapeutic avenues
  • Challenges existing paradigms in neuroscience by presenting the first comprehensive theories for a range of neurological and psychiatric conditions
  • Utilizes detailed references and robust scientific data to support groundbreaking claims and methodologies

CONTENTS

  • Chapter 1: A CRH2-ACTH theory of autism spectrum disorder
  • 1.1. Introduction
  • 1.2. Theory
  • 1.2.1. Urocortins (UCNs)
  • 1.2.2. Steroids (STRDs)
  • 1.2.3. Explaining ASD symptoms and properties
  • 1.3. Evidence
  • 1.3.1. Stress, CRH, ACTH
  • 1.3.2. Anatomical growth
  • 1.3.3. Growth agents & pathways
  • 1.3.4. Sex steroids
  • 1.3.5. Oxytocin
  • 1.3.6. Food intake
  • 1.4. Treatment
  • 1.4.1. Detection
  • 1.4.2. Preventive treatment
  • 1.4.3. Symptomatic treatment
  • 1.5. Discussion
  • List of abbreviations
  • Chapter 2: A CRH2-CRH1 theory of anorexia and bulimia
  • 2.1. Introduction
  • 2.2. Theory
  • 2.2.1. CRH, CRH1, CRH2, serotonin
  • 2.2.2. Anorexia nervosa (AN)
  • 2.2.3. Bulimia nervosa
  • 2.3. Evidence
  • 2.4. Treatment
  • 2.5. Discussion
  • List of abbreviations
  • Chapter 3: A polyunsaturated fatty acid (PUFA) theory of schizophrenia
  • 3.1. Introduction
  • 3.2. PUFA theory of schizophrenia (P*SZ)
  • 3.3. PUFAs and PUFA derivatives in health
  • 3.4. PUFAs and PUFA derivatives and stress
  • 3.5. Evidence for P*SZ
  • 3.5.1. PUFAs
  • 3.5.2. Immunity and pain
  • 3.5.3. ECB system
  • 3.5.4. Hyperexcitability: neuromodulators, hormones, neurotransmitters
  • 3.5.5. Coordinated network activity
  • 3.5.6. Summary
  • 3.6. Treatment
  • 3.7. Discussion
  • List of abbreviations
  • Chapter 4: A dynorphin theory of depression and bipolar disorder
  • 4.1. Introduction
  • 4.2. Stress responses and MDD
  • 4.3. A theory of opioids and survival responses
  • 4.4. A theory of depression and bipolar disorder
  • 4.5. Evidence
  • 4.6. Treatment
  • 4.7. Discussion
  • List of abbreviations
  • Chapter 5: A CRH-HCN theory of obsessive-compulsive disorder (OCD)
  • 5.1. Theory
  • 5.2. Treatment
  • 5.3. Key references
  • Chapter 6: A KATP channel theory of attention-deficit hyperactivity disorder
  • 6.1. Theory
  • 6.2. Treatment
  • 6.3. Evidence and references
  • Chapter 7: A sympathetic nervous system theory of migraine
  • 7.1. Introduction
  • 7.2. Theory
  • 7.2.1. SNS and BRRs
  • 7.2.2. TRPV1, CGRP
  • 7.2.3. Migraine
  • 7.3. Evidence
  • 7.3.1. Basal state
  • 7.3.2. Acute headache state
  • 7.4. Treatment
  • 7.5. Discussion
  • List of abbreviations
  • Chapter 8: A ceramide theory of multiple sclerosis
  • 8.1. Introduction
  • 8.2. Theory
  • 8.2.1. Background
  • 8.2.2. Multiple sclerosis
  • 8.3. Evidence
  • 8.4. Treatment
  • 8.5. Discussion
  • List of abbreviations
  • Chapter 9: A calcium channel α2δ subunit theory of amyotrophic lateral sclerosis and frontotemporal dementia
  • 9.1. Introduction
  • 9.2. Voltage-gated calcium channels (VGCCs)
  • 9.3. Proposed calcium & a2d impairment in ALS
  • 9.3.1. Motivation
  • 9.3.2. Calcium part of the theory
  • 9.3.3. a2d part of the theory
  • 9.4. ALS evidence
  • 9.4.1. Calcium
  • 9.4.2. Explanatory power for ALS facts
  • 9.4.3. a2d
  • 9.4.4. Insulin
  • 9.5. Autoimmunity
  • 9.6. Frontotemporal dementia (FTD)
  • 9.7. Discussion
  • Chapter 10: A galactose theory of Parkinson's disease
  • 10.1. Introduction
  • 10.2. T*PD theory of PD
  • 10.3. Evidence
  • 10.3.1. Gut bacteria, mucin
  • 10.3.2. Galactose
  • 10.3.3. Glucose
  • 10.3.4. Oxidative stress
  • 10.3.5. Sympathetic nervous system
  • 10.3.6. Risk & protective factors
  • 10.4. Treatment
  • 10.5. Discussion
  • List of abbreviations
  • Chapter 11: A lipid-raft theory of Alzheimer's disease
  • 11.1. Introduction
  • 11.1.1. Overview of the theory of adaptive response plasticity
  • 11.1.2. Overview of the lipid-raft theory of Alzheimer's disease
  • 11.2. The theory of adaptive response plasticity
  • 11.2.1. Double-edged plasticity
  • 11.2.2. Long-term potentiation and long-term depression
  • 11.2.3. The steady state
  • 11.2.4. Candidate generation
  • 11.2.5. Cholesterol, apolipoprotein E, and lipid rafts
  • 11.2.6. Competition resolution: winners and losers
  • 11.2.7. Summary
  • 11.3. The lipid-raft theory of Alzheimer's disease
  • 11.3.1. Mechanisms underlying symptoms and pathology
  • 11.3.2. Chronicity
  • 11.3.3. Cholesterol and amyloid β
  • 11.3.4. Tau
  • 11.3.5. Core cause
  • 11.3.6. Autosomal dominant Alzheimer's disease
  • 11.4. Evidence
  • 11.4.1. Lipid rafts
  • 11.4.2. Cholesterol
  • 11.4.3. Polyunsaturated fatty acids
  • 11.4.4. Plasticity agents
  • 11.4.5. Synapses
  • 11.4.6. Brain areas
  • 11.4.7. Genetics
  • 11.4.8. Other diseases
  • 11.5. Risk and protective factors
  • 11.5.1. Viral infections
  • 11.5.2. Traumatic brain injury
  • 11.5.3. Diabetes and obesity
  • 11.5.4. Vascular impairment
  • 11.5.5. Immunity
  • 11.5.6. Stress
  • 11.5.7. Smoking
  • 11.5.8. Education and bilingualism
  • 11.5.9. Exercise
  • 11.6. Discussion
  • 11.6.1. Related theories
  • 11.6.2. The theory of adaptive response plasticity
  • 11.6.3. Sleep
  • 11.6.4. Neurogenesis
  • 11.6.5. Dementia
  • 11.6.6. Theory predictions
  • Chapter 12: The brain's adaptive response process: function and anatomy
  • 12.1. Explaining the brain
  • 12.2. The adaptive response process (ARP)
  • 12.2.1. Response selection
  • 12.2.2. Response release: ARAR circuits
  • 12.2.3. Novel vs. Automated (learned) responses
  • 12.2.4. Agents
  • 12.3. IINs: competition resolution (cres) & execution
  • 12.4. Goals and predictions
  • 12.5. The basal ganglia and the cerebellum
  • 12.6. Hierarchical sequences (HSEQs)
  • 12.7. Additional evidence
  • 12.8. Discussion
  • 12.8.1. The explanatory power and biological logic of the theory
  • 12.8.2. Function and anatomy
  • 12.8.3. Other theories; contribution
  • 12.8.4. Action execution, observation, imagery
  • 12.8.5. Language
  • 12.8.6. Fully explaining the brain
  • 12.8.7. Consciousness and emotions
  • Author's comment
  • Chapter 13: The brain's ‘Allow, Restrain, Amplify, Respond’ (ARAR) architecture
  • 13.1. Introduction
  • 13.2. The D1 ARAR circuit
  • 13.3. The D2 circuit: automated (learned) responses
  • 13.3.1. The circuit
  • 13.3.2. Problems with the standard D2 account
  • 13.3.3. Evidence supporting a learned movement role of the D2 path
  • 13.4. The extended amygdala ARAR circuit
  • 13.5. The habenula ARAR circuit
  • 13.6. The superior colliculus ARAR circuit
  • 13.7. The hippocampus ARAR circuit
  • 13.8. The cerebellum ARAR circuit
  • 13.9. Discussion
  • Chapter 14: A comprehensive biological theory of sleep
  • 14.1. Introduction
  • 14.2. Theory overview
  • 14.3. Wake activity
  • 14.4. Homeostasis and its restoration
  • 14.5. NREM sleep
  • 14.6. REM sleep
  • 14.7. Consciousness
  • 14.8. Memory and plasticity
  • 14.9. Anesthesia
  • 14.10. Discussion
  • 14.11. Conclusio

Γράψτε μια αξιολόγηση

Σημείωση: η HTML δεν επεξεργάζεται!
Κακή Καλή
Ετικέτες: neurology , neuroscience , brain